Patents by Inventor Soumen Pattanayek

Soumen Pattanayek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GASTRO RETENTIVE DOSAGE FORMS COMPRISING DEUTETRABENAZINE
    Publication number: 20230390192
    Abstract: Provided herein are controlled release gastro retentive dosage forms containing deutetrabenazine for use in the treatment of, e.g., hyperkinetic movement disorders. When orally administered to a subject on a once-daily basis, the dosage forms provide a favorable pharmacokinetic profile.
    Type: Application
    Filed: October 12, 2021
    Publication date: December 7, 2023
    Inventors: Mayank JOSHI, Parag SHAH, Soumen PATTANAYEK, Divyang PATEL, Sandeep PANDITA
  • MULTIPARTICULATE DOSAGE FORMS COMPRISING DEUTETRABENAZINE
    Publication number: 20230364075
    Abstract: Provided herein are controlled release multiparticulate dosage forms containing deutetrabenazine for use in the treatment of, e.g., hyperkinetic movement disorders. When orally administered to a subject on a once-daily basis, the dosage forms provide a favorable pharmacokinetic profile.
    Type: Application
    Filed: September 17, 2021
    Publication date: November 16, 2023
    Inventors: Mayank JOSHI, Parag SHAH, Soumen PATTANAYEK, Divyang PATEL, Sandeep PANDITA
  • OSMOTIC DOSAGE FORMS COMPRISING DEUTETRABENAZINE AND METHODS OF USE THEREOF
    Publication number: 20230022862
    Abstract: Provided herein are osmotic dosage forms containing deutetrabenazine for use in the treatment of, e.g., hyperkinetic movement disorders. When orally administered to a subject on a once-daily basis, the dosage forms provide a favorable pharmacokinetic profile for the active agent indicating treatment efficacy over an extended period of time.
    Type: Application
    Filed: March 1, 2022
    Publication date: January 26, 2023
    Inventors: Parag Shah, Mayank Joshi, Soumen Pattanayek, Divyang Patel, Sandeep Pandita
  • OSMOTIC DOSAGE FORMS COMPRISING DEUTETRABENAZINE AND METHODS OF USE THEREOF
    Publication number: 20220296585
    Abstract: Provided herein are osmotic dosage forms containing deutetrabenazine for use in the treatment of, e.g., hyperkinetic movement disorders. When orally administered to a subject on a once-daily basis, the dosage forms provide a favorable pharmacokinetic profile for the active agent indicating treatment efficacy over an extended period of time.
    Type: Application
    Filed: June 8, 2022
    Publication date: September 22, 2022
    Inventors: Parag Shah, Mayank Joshi, Soumen Pattanayek, Divyang Patel, Sandeep Pandita
  • Osmotic dosage forms comprising deutetrabenazine and methods of use thereof
    Patent number: 11311488
    Abstract: Provided herein are osmotic dosage forms containing deutetrabenazine for use in the treatment of, e.g., hyperkinetic movement disorders. When orally administered to a subject on a once-daily basis, the dosage forms provide a favorable pharmacokinetic profile for the active agent indicating treatment efficacy over an extended period of time.
    Type: Grant
    Filed: June 10, 2021
    Date of Patent: April 26, 2022
    Assignee: AUSPEX PHARMACEUTICALS, INC.
    Inventors: Parag Shah, Mayank Joshi, Soumen Pattanayek, Divyang Patel, Sandeep Pandita
  • ELTROMBOPAG CHOLINE DOSAGE FORMS
    Publication number: 20220079883
    Abstract: Oral dosage forms comprising eltrombopag choline, processes for preparation thereof and methods of use thereof are disclosed. The compositions disclosed exhibit enhanced bioavailability and reduced food effect compared to commercially available formulations of eltrombopag.
    Type: Application
    Filed: September 13, 2021
    Publication date: March 17, 2022
    Inventors: Alap CHOUDHARI, Ashok Kumar THALLUR GOPI, Soumen PATTANAYEK, Parag SHAH, Mayank JOSHI
  • OSMOTIC DOSAGE FORMS COMPRISING DEUTETRABENAZINE AND METHODS OF USE THEREOF
    Publication number: 20210386673
    Abstract: Provided herein are osmotic dosage forms containing deutetrabenazine for use in the treatment of, e.g., hyperkinetic movement disorders. When orally administered to a subject on a once-daily basis, the dosage forms provide a favorable pharmacokinetic profile for the active agent indicating treatment efficacy over an extended period of time.
    Type: Application
    Filed: June 10, 2021
    Publication date: December 16, 2021
    Inventors: Parag Shah, Mayank Joshi, Soumen Pattanayek, Divyang Patel, Sandeep Pandita